# K993043: MS-30 Femoral Stem

- Pathway: 510(k) (Traditional)
- Applicant: Sulzer Orthopedics, Inc.
- Decided: Dec 2, 1999 after 83 days
- Product code: LZO (Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented)
- Device class: 2
- Regulation: 21 CFR 888.3353
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
19 later devices descend from it; 3 cite it directly.
0 of 20 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) DePuy Endurance Polished Stem: named in the summary without a submission number
- (no number) Howmedica Osteonics Exeter Hip Stem: named in the summary without a submission number
- (no number) Zimmer VerSys Cemented CT Hip Stem: named in the summary without a submission number
- (no number) Zimmer VerSys Heritage Hip Stem: named in the summary without a submission number

## Most influential descendants
- K083558: Medacta Total Hip Prosthesis System - Quadra C (2009), 9 descendants of its own
- K040803: MS-30 Femoral Stem Standard and Lateral (2004), 8 descendants of its own
- K192827: Quadra-P (2020), 6 descendants of its own
- K133370: Remedy Hip Stem, Pegasus Hip Stem, Evolve Helios Hip Stem, Evolve Masters Hip Stem, Evolve Distal Centralizer, Evolve CE (2014), 5 descendants of its own
- K202730: Quadra-P (2020), 1 descendant of its own

## Indications for use
The MS-30 Femoral Stem is intended for cemented use in treatment of the following: 1. Advanced wear of the joint due to degenerative, posttraumatic or rheumatic diseases. Fractures or vascular necroses. Status following earlier operations, such as joint reconstruction (osteotomy), arthrodesis, hemiarthroplasty of total hip prosthesis (THP).

Source page: https://510kreport.com/device/K993043
Methodology: https://510kreport.com/methodology